Clinical Trial Update: Anlotinib In Combination With Durvalumab As Sequential Therapy of Thoracic Radiotherapy After Induction Chemotherapy For Extensive-Stage Small Cell Lung Cancer:A Single Arm Study [Phase 2]

View source ↗

Summary

A Phase 2 single-arm trial evaluating sequential therapy with anlotinib followed by durvalumab after induction chemotherapy and thoracic radiotherapy in extensi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Durvalumab (durvalumab)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Anlotinib, Durvalumab | Phase 2 | Status: UNKNOWN